BRIEF-Merck KGaA's Bavencio drug wins EU approval for Merkel cell carcinoma
September 21, 2017 at 03:17 AM EDT
* European commission approves Bavencio (avelumab) for metastatic Merkel cell carcinoma For the full story: Further company coverage: